Keyphrases
Phenytoin
97%
Antiepileptic Drugs
90%
Seizure
69%
Epilepsy
63%
Carbamazepine
51%
Pharmacokinetics
41%
Patients with Epilepsy
38%
Felbamate
32%
Levetiracetam
31%
Status Epilepticus
28%
Partial Seizures
25%
Zonisamide
23%
Placebo
21%
Epilepsy Treatment
20%
Elderly Patients
20%
Phenobarbital
20%
Topiramate
20%
Epilepsy in Elderly
19%
Elderly nursing Home Residents
18%
Valproate
17%
Nursing Homes
16%
Lamotrigine
16%
Valproic Acid
15%
Gabapentin
15%
New Antiepileptic Drugs
15%
Clinical Trials
15%
Adverse Events
14%
Older Adults
13%
Tiagabine
13%
Drug Use
13%
Steady State
13%
Intractable Epilepsy
12%
Antiseizure Medication
12%
Serum Concentration
12%
Epilepsy Patients
11%
Drug Interactions
11%
Seizure Frequency
11%
Anticonvulsant
11%
Drug Concentration
10%
Plasma Concentration
10%
Nursing Home Residents
10%
Coefficient of Variation
10%
United States
9%
Seizure Type
9%
Refractory Epilepsy
9%
Epileptic Seizure
9%
Co-medication
9%
Epileptic Patients
9%
Age Groups
9%
Fosphenytoin
8%
Pharmacology, Toxicology and Pharmaceutical Science
Anticonvulsive Agent
100%
Phenytoin
87%
Pharmacokinetics
63%
Carbamazepine
44%
Sodium Valproate
33%
Placebo
31%
Felbamate
29%
Levetiracetam
26%
Focal Epilepsy
25%
Epileptic State
25%
Zonisamide
23%
Phenobarbital
21%
Lamictal
20%
Adverse Event
19%
Topiramate
18%
Disease
16%
Prevalence
16%
Gabapentin
15%
Tiagabine
13%
Clinical Trial
12%
Bioavailability
12%
Drug Interaction
11%
Fosphenytoin Sodium
11%
Epilepsy
10%
Intractable Epilepsy
10%
Side Effect
10%
Tolerability
9%
Drug Concentration
9%
Diseases
9%
Lorazepam
8%
Normal Human
8%
Add on Therapy
8%
Pharmacotherapy
7%
Complex Partial Seizure
7%
Cerebrovascular Accident
6%
Cannabidiol
6%
Drug Resistant Epilepsy
6%
Diazepam
6%
Oxcarbazepine
6%
Elimination
5%
Dose Concentration
5%
Oral Contraceptive
5%
Clonazepam
5%
Protein Binding
5%
Clinical Study
5%